A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics

Journal of Molecular Diagnostics

Volumn 7, Issue 2, 2005, Pages 247-251

  Jarvis, Michael ^a,e   Iyer, Ramaswamy K ^a,f   Williams, Laurina O ^b   Noll, Walter W ^c   Thomas, Kirk ^d   Telatar, Milhan ^a   Grody, Wayne W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e Specialty Laboratories   (United States)

^f Myriad Genetic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GENOMIC DNA; PLASMID DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CLINICAL GENETICS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DETERMINATION; EXPERIMENTAL DESIGN; GENE MUTATION; GENETIC ANALYSIS; HEALTH CARE ORGANIZATION; HETEROZYGOSITY; HOMOZYGOSITY; LABORATORY TEST; MASS SCREENING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PILOT STUDY; QUALITY CONTROL; SITE DIRECTED MUTAGENESIS; WILD TYPE;

BACTERIA (MICROORGANISMS);

EID: 18744370202     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60551-X     Document Type: Article

References (12)

1. Grody WW: Proficiency testing in diagnostic molecular pathology. Diagn Mol Pathol 1994, 3:221-223
2. Dequeker E, Ramsden S, Grody WW, Stenzel TT, Barton DE: Quality in molecular genetic testing. Nat Rev Genet 2001, 2:717-723
3. Richards CS, Grody WW: Alternative approaches to proficiency testing in molecular genetics. Clin Chem 2003, 49:717-718
4. Williams LO, Cole EC, Lubin IM, Iglesias NI, Jordan RL, Elliott LE: Quality assurance in human molecular genetics testing: status and recommendations. Arch Pathol Lab Med 2003, 127:1353-1358
5. Bernacki SH, Stankovic AK, Williams LO, Beck JC, Herndon JE, Snow-Bailey K, Prior TW, Matteson KJ, Wasserman LM, Cole EC, Stenzel TT: Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing. J Mol Diagn 2003, 5:227-230
6. Grody WW, Cutting G, Klinger K, Richards CS, Watson MS, DesnickRJ: Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001, 3:149-154
7. Grody WW, Desnick RJ, Carpenter NJ, Noll WW: Diversity of cystic fibrosis mutation screening practices. Am J Hum Genet 1998, 62:1252-1254
8. Zielenski J, Tsui L-C: Cystic fibrosis: genotypic and phenotypic variations. Ann Rev Genet 1995, 29:777-807
9. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs EM, Strom CM, Richards CS, Witt DR, Grody WW: Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 2004, 6:387-391
10. Makowski GS, Nadeau FL, Hopfer SM: Single tube multiplex PCR detection of 27 cystic fibrosis mutations and 4 polymorphisms using neonatal blood samples collected on Guthrie cards. Ann Clin Lab Sci 2003, 33:243-250
11. Grody WW: Quest for controls in molecular genetics. J Mol Diagn 2003, 5:209-211
12. Palomaki GE, Bradley LA, Richards CS, Haddow JE: Analytic validity of cystic fibrosis testing: a preliminary estimate. Genet Med 2003, 5:15-20